Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Præsentation
Citationsformater

Hansen, Peter Riis
Klaus Rieneck
Klaus Bendtzen

The mineralocorticoid receptor antagonist spironolactone (SPIR) reduces the mortality and morbidity in patients with congestive heart failure (CHF). Overexpression of proinflammatory cytokines contribute to the development and progression of CHF.

Originalsprog	Engelsk
Tidsskrift	Immunology Letters
Vol/bind	91
Udgave nummer	2-3
Sider (fra-til)	87-91
Antal sider	5
ISSN	0165-2478
DOI	https://doi.org/10.1016/j.imlet.2003.11.008
Status	Udgivet - 15 feb. 2004

ID: 34077034